Gastrointestinal cancer: Salvage chemotherapy in gastric cancer - More than a straw?

Nature Reviews Clinical Oncology

Volumn 9, Issue 6, 2012, Pages 312-313

  Lordick, Florian ^a  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CISPLATIN; DOCETAXEL; FLUOROPYRIMIDINE DERIVATIVE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; MITOMYCIN; PLATINUM COMPLEX; TAXANE DERIVATIVE;

ADVANCED CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RESISTANCE; CANCER STAGING; DRUG SAFETY; DRUG TREATMENT FAILURE; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SALVAGE THERAPY; STOMACH CANCER; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DRUG RESISTANCE, NEOPLASM; HUMANS; PROGNOSIS; SALVAGE THERAPY; STOMACH NEOPLASMS; TAXOIDS;

EID: 84861724755     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.76     Document Type: Review

References (10)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics. CA Cancer J. Clin. 62, 10-29 (2012).
2. Kamangar, F., Dores, G. M. & Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24, 2137-2150 (2006). (Pubitemid 46655601)
3. Wagner, A. D. et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J. Clin. Oncol. 24, 2903-2909 (2006). (Pubitemid 46630593)
4. Kang, J. H. et al. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2011. 39.4585.
5. Koizumi, W. et al. S. 1 plus cisplatin versus S. 1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 3, 215-221 (2008).
6. Temel, J. S. et al. Early palliative care for patients with metastatic non small cell lung cancer. N. Engl. J. Med. 363, 733-742 (2010).
7. Thuss-Patience, P. C. et al. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer-a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Eur. J. Cancer 47, 2306-2314 (2011).
8. Strong, V. E. et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann. Surg. 251, 640-646 (2010).
9. Messager, M. FREGAT working group-FRENCH. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann. Surg. 254, 684-693 (2011).
10. Tan, I. B. et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology. 141, 476-485 (2011).